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EDITORIAL
Unsuspected Pulmonary Emboli in Oncology Patients
Undergoing Routine Computed Tomography Imaging
Gregory W. Gladish, MD, and Jeremy J. Erasmus, MD
Pulmonary embolism is an increasingly recognized occurrence in asymptomatic pa-tients.1–4 Although the clinical guidelines for the treatment of symptomatic patients
with acute pulmonary emboli, based on several large multicenter trials,5 reduces the risk
of fatality to approximately 2%, the details regarding risk, prevalence, usefulness of
anticoagulation therapy, and outcome in patients with asymptomatic emboli are less well
defined. The study by Browne et al.,6 reported in this issue of the Journal of Thoracic
Oncology, adds to the growing body of literature addressing the prevalence and clinical
significance of pulmonary emboli in asymptomatic patients. The authors focus on a group
of patients at higher risk for pulmonary emboli than the general population. Specifically,
the authors report their experience in detecting pulmonary emboli in asymptomatic
oncology patients, and their study contributes to a better understanding of the prevalence,
predisposing factors, and outcomes of unsuspected pulmonary emboli. Browne et al.
prospectively evaluated 407 patients during a 10-month period for the presence of
unsuspected/asymptomatic pulmonary embolism and the associated risk factors, and
6-month clinical outcome in those patients with emboli. Browne et al. observed a 4.4%
prevalence of unsuspected pulmonary embolism, 6.4% among inpatients, and 3.4% among
outpatients. These data correspond well with other reports of a 3% to 6% prevalence of
incidental pulmonary emboli among oncology patients.1–4 In addition, the authors iden-
tified recent chemotherapy as the only significant predictor of unsuspected pulmonary
embolism.
The authors also evaluated the effect of image slice thickness on the detection of
unsuspected emboli. Browne et al. visualized pulmonary emboli confidentially on 1- to
1.5-mm thick images, whereas in 39% of cases these emboli were not detected on 5-mm
thick images. This finding is not unexpected as the use of thinner slices is well known to
improve the detection of emboli, especially segmental or smaller emboli, in symptomatic
patients.7 Most of the reports on the detection of unsuspected pulmonary emboli have
evaluated a slice thickness of 3.75 mm and yielded similar prevalence among oncology
patients. Interestingly, a report of the prevalence of unsuspected pulmonary embolism by
Cronin et al.8 (that includes some of the authors of this study), performed using thick
slices, inexplicably (considering that 8-mm thick images were used), reported only a
slightly lower prevalence of unsuspected pulmonary embolism of 3.3%.
The distribution of pulmonary emboli reported by Browne et al. is similar to our
reported experience4 in that approximately 50% of patients had lobar or larger emboli,
whereas 50% had only segmental or smaller emboli. This high prevalence of segmental or
smaller emboli and their poor visualization on thick images highlights the needs for thin
images in the evaluation for unsuspected pulmonary embolism. However, the optimal
slice thickness for balancing the detection for small abnormalities, such as segmental and
subsegmental pulmonary emboli, with radiation dose and image noise of the thinner
images, has not been definitively determined. It is likely that evaluation for small
pulmonary emboli on routine computed tomography studies requires a slice thickness of
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3.75 mm, and this study suggests that 5-mm thick images is
not adequate for that evaluation. However, the major ques-
tion, not addressed by this study, is the clinical significance of
the small emboli that would not be detected on the 5-mm
thick images. In this regard, Browne et al. report that the
detection of unsuspected pulmonary emboli changed patient
management and that there was an institution of directed
therapy for all but one patient. Other reports on the preva-
lence of unsuspected emboli also indicate that most patients
are treated.2–5,8–10 However, there is currently no strong
evidence to guide the treatment of patients with unsuspected
emboli. Although it has been reported that there are no
adverse outcomes in untreated patients, recurrent emboli and
deep vein thrombosis as well as respiratory-related mortality
among patients with small untreated emboli have been re-
ported. Unfortunately, this study does not clarify this issue,
although the only untreated patient (who had an unsuspected
isolated segmental pulmonary embolism) developed multiple
larger, symptomatic emboli 5 weeks after the detection of the
initial emboli.
Another interesting observation by Browne et al. is that
2.5% of patients without pulmonary emboli on the initial
computed tomography developed symptomatic or unsus-
pected pulmonary emboli in the 6-month follow-up period.
This occurrence would seem to indicate that thromboses and
emboli are constantly occurring and resolving in this subset
of patients with cancer and complicates the decision whether
these patients can be observed without instituting anticoagu-
lation therapy. Because pulmonary emboli can be a marker
for subsequent thromboembolic disease, current clinical prac-
tice in most institutions includes initiation of anticoagulation
therapy in patients with unsuspected pulmonary embolism.
However, the identification of those patients at high risk for
recurrent emboli and the most appropriate anticoagulation
regimen, including the duration of treatment, has not been
determined. In this regard, the pertaining published literature
is inconclusive and further study is needed to determine who
would benefit from anticoagulation and the optimal regimen
of anticoagulation among these patients. It is important to
state that a significant limitation of this study with respect to
evaluating the outcomes of therapy is the relatively small
number of patients with pulmonary emboli and the fact that
the specific treatment regimens used were not clarified. The
authors report that there were no recurrent emboli or therapy-
related complications among the treated patients. This ab-
sence of any therapy-related complications stands in contrast
to the report by Engelke et al.11 Notably, therapy in the study
by Engelke et al. included the use of thrombolytic therapy
with its higher risk of bleeding complications.
In summary, Browne et al. have added to the develop-
ing literature on the prevalence of unsuspected emboli in
oncology patients. In addition to the 4.4% prevalence of
asymptomatic pulmonary emboli, they have importantly
raised issues pertaining to therapeutic management by report-
ing a 2.5% incidence of pulmonary emboli in the 6 months
after the initial diagnosis in their patient group. Interestingly,
the authors have also confirmed that, regardless of size of the
emboli, there is an alteration of patient management when
pulmonary emboli are detected. Specifically, anticoagulation
therapy is typically instituted even though the data supporting
therapeutic management is unclear.
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